Fundraising FoxAsclepius Life Sciences Fund, LP
Venture capitalNew York · Seed–Series B · 3 people tracked
Find your way into Asclepius Life Sciences Fund, LP
Sign up to see every warm intro you have to Asclepius Life Sciences Fund, LP
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Asclepius Life Sciences Fund, LP team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Asclepius invests exclusively in private-market life sciences companies, spanning healthcare, pharmaceuticals, agriculture, personal care, biosciences and biotechnology. The fund seeks to exploit market inefficiencies by combining operational expertise, deep scientific insight and rigorous financial analysis, drawing on a leadership team with extensive experience across investment, biopharmaceuticals, life sciences and healthcare management.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from the firm's website & public directoriesGlover has 30+ years of experience in biopharmaceuticals and life sciences, with a background spanning turnarounds, business strategy, corporate development, and commercialization across 25+ transactions worth over $10 billion. He is co-founder, President and CEO of ZyVersa Therapeutics and previously co-founded Coherus BioSciences.
Dr. Gerst focuses on biopharma and medical technology and holds Series 7 and Series 65 securities licenses. A physician trained at Columbia with multiple business degrees, he has held senior roles at PwC, Columbia/HCA, Crawford & Company and Premier, and works on connected health platforms.
Mackey has over 30 years in global financial services and represents the Fund globally. He is CEO and founder of MLG Capital in The Bahamas and previously held executive roles at RBC, EFG International and Credit Suisse across multiple countries.
Frequently asked questions
- What stage does Asclepius Life Sciences Fund, LP invest at?
- Asclepius Life Sciences Fund, LP invests at the Seed, Series A, Series B stages.
- What sectors does Asclepius Life Sciences Fund, LP focus on?
- Asclepius Life Sciences Fund, LP focuses on AgTech, Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Asclepius Life Sciences Fund, LP located?
- Asclepius Life Sciences Fund, LP is headquartered in New York, US.
Images
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Investinor AS is a Norwegian state-backed investment company that partners with founders, entrepreneurs and other investors to help selected promising companies become world-leading.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Lerer Hippeau is an early-stage venture capital firm that backs founders across sectors, emphasizing investing in companies before they gain wider recognition.
Novo Holdings is the investment arm of the Novo Nordisk Foundation and a leading life science investor that also manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity assets.